Filing Details
- Accession Number:
- 0001453814-18-000150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-04 16:18:20
- Reporting Period:
- 2018-12-03
- Accepted Time:
- 2018-12-04 16:18:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1453814 | Medidata Solutions Inc. | MDSO | Services-Prepackaged Software (7372) | 522319066 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1641826 | Rouven Bergmann | C/O Medidata Solutions, Inc. 350 Hudson Street, 9Th Floor New York NY 10014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-12-03 | 10,000 | $53.29 | 88,862 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-12-03 | 10,000 | $79.00 | 78,862 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2018-12-03 | 10,000 | $0.00 | 10,000 | $53.29 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,643 | 2025-05-13 | No | 4 | M | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
- The options vested as to 25% of the shares on May 13, 2016 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.